Radiation Oncology/Therapy: Page 129

U.S. proton therapy market to reach $1B by 2022

By AuntMinnie.com staff writers

The U.S. proton therapy market is expected to reach $1 billion in revenues by 2022, growing at a compound annual growth rate of more than 16%, according to a new report from Research and Markets.

October 12, 2016

What do oncologists want from radiology?

By AuntMinnie.com staff writers

Oncologists would like to see a number of improvements in the service provided by radiologists, according to a new report published by Swedish PACS vendor Sectra.

October 3, 2016

Shortened RT works for low-risk prostate cancer patients

By AuntMinnie.com staff writers

A shortened, higher-dose radiation therapy (RT) protocol is safe for low-risk prostate cancer patients and is associated with lower costs and similar quality-of-life outcomes, according to research presented at the recent American Society for Radiation Oncology meeting in Boston.

October 3, 2016

Elekta highlights ASTRO MR-linac research

By AuntMinnie.com staff writers

Radiation oncology firm Elekta is highlighting research presented at the recent American Society for Radiation Oncology (ASTRO) conference in Boston on the use of the company's work-in-progress high-field MR-adaptive linear accelerator (MR-linac) for radiation therapy.

September 28, 2016

ASCO releases updated breast RT guideline

By AuntMinnie.com staff writers

The American Society of Clinical Oncology (ASCO) has released an updated guideline for the use of postmastectomy radiotherapy (RT).

September 28, 2016

ASTRO: Radiation boost cuts local recurrence in DCIS patients

By AuntMinnie.com staff writers

A supplemental boost of radiation cuts breast cancer recurrence in women with ductal carcinoma in situ (DCIS) who receive whole-breast radiation therapy following lumpectomy, according to a presentation at the recent American Society for Radiation Oncology (ASTRO) conference in Boston.

September 27, 2016